top of page

Our Story

The Leading Biotechnology Startup

We’re a diverse and talented group of entrepreneurs and scientists with a groundbreaking idea designed to contribute towards a better tomorrow. At BCAL Diagnostics, we believe that the right scientific understanding and technological edge can lead to better diagnostics and a healthier future. Contact us today to set up a meeting to get involved in changing the face of cancer detection - Together.

The BCAL Diagnostics Team

Get to Know Us

Jayne Shaw.jpeg

Jayne Shaw

Chairman & Co-Founder

Trained as a Registered Nurse in the UK, on arrival in Australia she became a Director of Nursing and Chief Executive Officer of two private hospitals. Following this she established an Australian and International  consulting business which was sold to Healthsouth a large US Healthcare company. After  this she became the Co-founder of Vision Group an Opthalmic Doctor equity consolidation model which was successfully listed on the ASX. Jayne joined a number of private Healthcare Boards involved with specialist consolidation including Cardiology, Orthopaedics, and Women’s Health she continued to work with Private Equity firms on local and International Healthcare transactions. Jayne, together with Ron Phillips was a co-owner of Sydney Breast Clinic and a co-founder of BCAL Diagnostics. Current Board positions are Critical Group – Heatley’s Industrial Supplies, The Woolcock Research Institute, and The Hareda Foundation established to invest in Women’s Health Initiatives.

Ron Phillips.jpg

The Hon Ron Philips (AO)

Director & Co-Founder

Following 15 years in the NSW Parliament which included serving as Minister for Health and Deputy Leader of the Opposition, Ron developed a successful consulting business in the Health and Aged Care Industry.
His business interests included co-owner and Managing Director of Sydney Breast Clinic which he sold to Healthscope. He currently serves as Chair of the Sydney Local Health District and as Director on Westmead IVF.

Dr Amani Batarseh

Dr Amani Batarseh, PhD

Chief Scientist

Dr Amani Batarseh is the company’s Chief Scientist. She graduated magna cum laude from La Roche College in Pennsylvania where she had a Pacem in Terris scholarship for academic excellence. Later, she received a fellowship to purse her PhD at Georgetown University, Washington, DC in Biochemistry and Molecular & Cellular Biology. Amani completed post doctoral studies at Harvard University, McGill University and Wollongong University. During her time in Canada, Amani managed and established two mass spectrometry laboratories being at the Research Institute of McGill University Hospital and The Glen Hospital in Montreal, respectively. Her versatile profile of expertise combines molecular biology with lipidomics and mass spectrometry to answer biological questions.

Kerry Heffernan.jpg

Kerry Heffernan

Research Assistant

Kerry is the company’s Research Assistant. Kerry recently graduated with First Class Honours from the University of Sydney. He presented his Honours project at the 2019 ASCEPT-PAGANs conference in Queenstown NZ.
Kerry as a diverse range of professional interests including health, carcinogenesis, machine learning, programming and metabolomics.


Jonathan Trollip

Commercial Consultant

Jonathan is a globally experienced independent director with over 30 years commercial, corporate, governance and legal and transactional expertise.
Jonathan is currently non-executive independent chairman of ASX listed Global Value Fund Ltd Future Generation Investment Company Ltd , Antipodes Global Investment Company Ltd and Plato Income Maximizer Limited . He is a non-executive director of ASX listed Kore Potash Limited and holds private company directorships in the commercial and not-for-profit sectors.
Jonathan was a principal of Sydney, Australia based structured finance group Meridian International Capital Limited for over 20 years, Prior to that, Jonathan was a partner with law firm Herbert Smith Freehills. Jonathan currently has a New South Wales Law Society Practicing Certificate and is a Fellow of the Australian Institute of Company Directors.

kim ekroos.jpg

Dr Kim Ekroos, PhD

Lipidomics Scientific Advisor

Kim Ekroos is the founder and CEO of Lipidomics Consulting Ltd., a consulting business providing unique services for customers globally in the field of Lipidomics. He received his Ph.D. degree in biology from the Technical University in Dresden, Germany, in 2003. His expertise includes high-throughput technologies for the precise assessment of lipidomes enabled by advanced mass spectrometry, automation, and software tools towards discovery of biological architectures and of diagnostic biomarkers for clinical purpose.
Kim is a globally experienced independent consultant for Lipidomics with over 20 years academics, healthcare and industry expertise. He has a number of patents for biomarker discovery, numerous peer-reviewed publications and an editor of a widely read Lipidomics book. He is the current president of the newly founded International Lipidomics Society (ILS) to which the Lipidomics Standards Initiative (LSI) belongs that focuses on standardisation of Lipidomics studies.

bottom of page